Holford NHG and Sheiner LB "Understanding the Dose-Effect Relationship-Clinical Application of Pharmacokinetic-Pharmacodynamic Models", Clin Pharmacokin 6:429-453 (1981)-The Backstory.
作者信息
Holford Nick
机构信息
Clinical Pharmacology, University of Auckland, New Zealand.
出版信息
AAPS J. 2011 Dec;13(4):662-4. doi: 10.1208/s12248-011-9306-5. Epub 2011 Oct 18.
Abstract
摘要
相似文献
1
Holford NHG and Sheiner LB "Understanding the Dose-Effect Relationship-Clinical Application of Pharmacokinetic-Pharmacodynamic Models", Clin Pharmacokin 6:429-453 (1981)-The Backstory.
AAPS J. 2011 Dec;13(4):662-4. doi: 10.1208/s12248-011-9306-5. Epub 2011 Oct 18.
2
Pharmacokinetic-pharmacodynamic relationship.
Ann Rech Vet. 1990;21 Suppl 1:29S-40S.
3
Relationship between pharmacokinetic half-life and pharmacodynamic half-life in effect-time modeling.
Int J Clin Pharmacol Ther. 1998 Mar;36(3):168-75.
4
Current and future directions of pharmacokinetic and pharmacokinetic-pharmacodynamic modelling and simulation: population approach group in Europe 19th annual meeting.
Expert Opin Drug Metab Toxicol. 2010 Dec;6(12):1599-604. doi: 10.1517/17425255.2010.529899. Epub 2010 Oct 24.
5
Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics.
Anesthesiology. 2003 Aug;99(2):324-33. doi: 10.1097/00000542-200308000-00014.
6
Pharmacokinetic and pharmacodynamic variability: a daunting challenge in drug therapy.
Curr Drug Metab. 2007 Feb;8(2):109-36. doi: 10.2174/138920007779816002.
7
The maximum pharmacodynamic effect as a response parameter: pharmacokinetic considerations.
J Pharm Pharmacol. 1999 Sep;51(9):999-1008. doi: 10.1211/0022357991773465.
8
Pharmacokinetic and pharmacodynamic modeling in vivo.
Crit Rev Bioeng. 1981;5(4):273-322.
9
Simultaneous pharmacokinetic and pharmacodynamic modeling.
J Pharmacokinet Biopharm. 1981 Jun;9(3):367-88. doi: 10.1007/BF01059272.
10
Relevance of the application of pharmacokinetic-pharmacodynamic modelling concepts in drug development. The "wooden shoe' paradigm.
Clin Pharmacokinet. 1997 Apr;32(4):259-67. doi: 10.2165/00003088-199732040-00001.
引用本文的文献
1
Safety, tolerability, pharmacokinetics and pharmacodynamics of a novel farnesoid X receptor (FXR) agonist-TQA3526 in healthy Chinese volunteers: a double-blind, randomized, placebo-controlled, dose-escalation, food effect phase I study.
Ann Med. 2023;55(2):2264850. doi: 10.1080/07853890.2023.2264850. Epub 2023 Dec 10.
2
Influence of input rates on (+/-)-isradipine haemodynamics and concentration-effect relationship in healthy volunteers.
Eur J Clin Pharmacol. 1994;46(1):29-33. doi: 10.1007/BF00195912.
3
Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.
Cardiovasc Drugs Ther. 1989 Jun;3(3):417-25. doi: 10.1007/BF01858113.
4
Pharmacodynamics of methylprednisolone phosphate after single intravenous administration to healthy volunteers.
Pharm Res. 1991 Feb;8(2):263-8. doi: 10.1023/a:1015864709082.
本文引用的文献
1
Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatments.
J Pharmacokinet Pharmacodyn. 2006 Jun;33(3):281-311. doi: 10.1007/s10928-006-9012-6. Epub 2006 Apr 20.
2
Some quantitative uses of drug antagonists.
Br J Pharmacol Chemother. 1959 Mar;14(1):48-58. doi: 10.1111/j.1476-5381.1959.tb00928.x.
3
Quantitative analysis of the disopyramide concentration-effect relationship.
Br J Clin Pharmacol. 1980 Jan;9(1):67-75. doi: 10.1111/j.1365-2125.1980.tb04799.x.
4
Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.
Clin Pharmacokinet. 1981 Nov-Dec;6(6):429-53. doi: 10.2165/00003088-198106060-00002.
5
Pharmacokinetic and pharmacodynamic modeling in vivo.
Crit Rev Bioeng. 1981;5(4):273-322.
6
Kinetics of pharmacologic response.
Pharmacol Ther. 1982;16(2):143-66. doi: 10.1016/0163-7258(82)90051-1.
7
Discrimination of three types of opioid binding sites in rat brain in vivo.
Mol Pharmacol. 1984 Mar;25(2):242-8.
8
Prednisolone pharmacodynamics assessed by inhibition of the mixed lymphocyte reaction.
Transplantation. 1982 Jun;33(6):578-84. doi: 10.1097/00007890-198206000-00002.
9
Kinetics of interaction between drugs and biological systems.
Farmaco Sci. 1968 Oct;23(10):907-18.
10
Computer-aided long-term anticoagulation therapy.
Comput Biomed Res. 1969 Dec;2(6):507-18. doi: 10.1016/0010-4809(69)90030-5.
Zotero 插件